Company news
TheraCryf PLC news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Rule 2.10 Announcement
September 7, 2011
Offer approach
August 3, 2011
Possible Acquisition
July 19, 2011
Blocklisting Interim Review
June 14, 2011
Annual Information Update
May 25, 2011
2010 Annual Financial Report
April 12, 2011
Appointment of Broker
March 24, 2011
Starmine Analyst Awards
March 9, 2011
New Primary Retail Bond Business
February 18, 2011
Financial Services Compensati
January 26, 2011
Trading Statement
January 24, 2011
Additional Listing - Block Li
November 8, 2010
Statement regarding Panmure G
October 19, 2010
Rule 8 statement re Panmure G
September 23, 2010
Doc re. Half Yearly Report
August 27, 2010
Other Directorship
July 2, 2010
2009 Annual Financial Report
April 16, 2010
Preliminary Statement
March 25, 2010
Pre-Close Trading Statement
February 1, 2010
Appointment of Non-Executive
January 27, 2010
Result of EGM
January 22, 2010
Notice of General Meeting
December 23, 2009
Remuneration Committee Appoin
November 20, 2009
2008 Annual Financial Report
April 17, 2009
Preliminary Results
April 8, 2009
Re Joint Venture
April 1, 2009
Pre-close Trading Statement
February 6, 2009
Acquisition
October 21, 2008
Annual Report and Accounts
April 28, 2008
Other Directorships
January 11, 2008
Additional Listing
December 20, 2007
Director/PDMR Shlding-Amend
July 11, 2007
Response to FSA Statement
January 18, 2007
Transaction in Own Shares
January 8, 2007
Calls
The 5 newest of 12 calls. Every call is listed under its year.
- Theracryf (LSE:TCF) — Update on the Ox-1 programme
Oct 20, 2026
Transcript - Theracryf (LSE:TCF) — Final Results for the year ended 31 March 2026
Sep 28, 2026
Transcript - Theracryf (LSE:TCF) — Investor Presentation
Apr 24, 2026
Transcript - Theracryf (LSE:TCF) — Half year results for the six months to 30 September 2025
Dec 3, 2025
Transcript - Theracryf (LSE:TCF) — Ox-1 – A deep dive into TheraCryf’s addiction programme
Jun 11, 2025
Transcript
Decks
The 5 newest of 15 decks. Every deck is listed under its year.
- Shareholder Meeting (September 2026)
Shareholder meeting · 14 slides · Sep 7, 2026
- Investor Presentation (November 2025)
Investor deck · 21 slides · November 2025
- Investor Presentation (February 2025)
Investor deck · 22 slides · February 2025
- Investor Presentation (May 2024)
Investor deck · 12 slides · May 2024
- Evgen Pharma — Merger or Acquisition (April 2024)
Merger or acquisition · 12 slides · April 2024